Search
Search Funnelback University
21 -
30 of
46
search results for `vasculitis and lupus`
Fully-matching results
-
Dr Luis F. Quintana | Cambridge Immunology Network
https://www.immunology.cam.ac.uk/Networkdirectory/quintana23 Feb 2024: Search site. Cambridge Immunology Network. Dr Luis F. Quintana. Biomarker studies in ANCA-associated vasculitis, lupus and immune-mediated renal disease. ... We perform state-of-the-art proteomic analyses on plasma and urine samples of patients with -
immune-mediated disease Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/immune-mediated-disease/feed/19 Jul 2024: PredictImmune and I’m honoured to have beenappointed to lead the company as it enters the commercialisation phase of its expansion. ... potentialbr / long-term value.”/p pImmune-mediated diseases, such as inflammatory bowel disease, vasculitis and -
For staff - Ketan Patel
https://www.staff.admin.cam.ac.uk/taxonomy/term/4707/feed19 Jul 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in -
Dr Aladdin Mohammad | Cambridge Immunology Network
https://www.immunology.cam.ac.uk/Networkdirectory/mohammad23 Feb 2024: At the Department of Rheumatology, Lund University in Sweden, I am the PI of a comorbidity project addressing the frequencies and predictors of common morbidities in ANCA vasculitis and giant cell ... In June 2013, I joined a postdoctoral research -
For staff - Peter McNaughton
https://www.staff.admin.cam.ac.uk/taxonomy/term/5352/feed19 Jul 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in -
Predictimmune Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/predictimmune/feed/19 Jul 2024: Whilst lupus can be controlled through lifestyle changes and medical interventions, there is currently no cure. ... potentialbr / long-term value.”/p pImmune-mediated diseases, such as inflammatory bowel disease, vasculitis and Lupus are common, -
For staff - Sadaf Farooqi
https://www.staff.admin.cam.ac.uk/taxonomy/term/5610/feed19 Jul 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in -
Clinicians | Cambridge Immunology Network
https://www.immunology.cam.ac.uk/Networkdirectory/clinicians23 Feb 2024: Senior Lecturer Transfusion Medicine. Arthritis Research UK rheumatology lecturer. Wellcome-Beit Prize and Intermediate Clinical Fellow. ... 01223 762127. Honorary Consultant, Vasculitis and Lupus Clinic, Cambridge University Hospitals. -
For staff - Magdalena Zernicka-Goetz
https://www.staff.admin.cam.ac.uk/taxonomy/term/4857/feed19 Jul 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in -
Dr David Jayne | Cambridge Immunology Network
https://www.immunology.cam.ac.uk/Networkdirectory/jayne23 Feb 2024: Search site. Cambridge Immunology Network. Dr David Jayne. Clinical evaluation of newer immunotherapeutics in vasculitis, lupus and immune-mediated renal disease. ... Co-ordination of international clinical research vasculitis network (EUVAS) and
Refine your results
Format
Date
- 39 Past 6 months
- 39 2024
- 39 Past year
- 12 Past 3 months
- 12 Past fortnight
- 12 Past month
- 12 Past week
- 3 Uncertain
- 2 2022
- 1 Today
- 1 2023
- 1 2013
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.